{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:35:55Z","timestamp":1793777755731,"version":"4.6.1"},"reference-count":266,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejca.2023.113251","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T18:35:37Z","timestamp":1690569337000},"page":"113251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention\u2013Update 2023"],"prefix":"10.1016","volume":"193","author":[{"given":"Alexander J.","family":"Stratigos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4832-3410","authenticated-orcid":false,"given":"Clio","family":"Dessinioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Lebbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"van Akkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-9826","authenticated-orcid":false,"given":"Lars","family":"Bastholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Dreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-7883","authenticated-orcid":false,"given":"Ana Maria","family":"Forsea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hauschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-0227","authenticated-orcid":false,"given":"Christoph","family":"Hoeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija","family":"Kandolf-Sekulovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole WJ","family":"Kelleners-Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-0964","authenticated-orcid":false,"given":"Aimilios","family":"Lallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"del Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moreno-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pellacani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Saiag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto","family":"Trakatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Ioannides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Zalaudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Arenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.M.","family":"Eggermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"R\u00f6cken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lorigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2023.113251_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2020.01.007","article-title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: part 1. epidemiology, diagnostics and prevention","volume":"128","author":"Stratigos","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2020.01.008","article-title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: part 2. Treatment","volume":"128","author":"Stratigos","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib3","first-page":"ed2023","article-title":"National comprehensive cancer network (NCCN) clinical practice guidelines in oncology","volume":"version 1","author":"Schmults","year":"2023","journal-title":"Squamous Cell Skin Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bjd.19621","article-title":"British association of dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020","volume":"184","author":"Keohane","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib5","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.ejca.2023.113251_bib6","unstructured":"Howick J., Chalmers I., Glasziou P., Greenhalgh T., Heneghan C., Liberati A., et al. The Oxford levels of evidence 2, Available at: \u3008https:\/\/wwwcebmoxacuk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence\u3009 Accessed on July 17, 2022: Oxford center for evifdence-based medicine."},{"key":"10.1016\/j.ejca.2023.113251_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamadermatol.2022.5508","article-title":"Association of patient risk factors, tumor characteristics, and treatment modality with poor outcomes in primary cutaneous squamous cell carcinoma: a systematic review and meta-analysis","volume":"159","author":"Zakhem","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib8","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1158\/1078-0432.CCR-18-1122","article-title":"Keratinocyte carcinomas: current concepts and future research priorities","volume":"25","author":"Nagarajan","year":"2019","journal-title":"Clini\u00a0Cancer\u00a0Res"},{"key":"10.1016\/j.ejca.2023.113251_bib9","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/bjd.16536","article-title":"Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses","volume":"180","author":"Schmitz","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jdv.12848","article-title":"Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin","volume":"29","author":"Fernandez-Figueras","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113251_bib11","unstructured":"FDA. Libtayo (cemiplimab-rwlc) full prescribing information. Available at: \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/761097s000lbl.pdf\u3009 Access date: 15 July 2019."},{"key":"10.1016\/j.ejca.2023.113251_bib12","unstructured":"European Medicines Agency. Libtayo. Summary of product characteristics. Available at: \u3008https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/libtayo-epar-product-information_en.pdf\u3009 Access date: 17 July 2019."},{"key":"10.1016\/j.ejca.2023.113251_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.113251_bib14","series-title":"TNM Classification of Malignant Tumours","author":"Union for International Cancer Control","year":"2017"},{"key":"10.1016\/j.ejca.2023.113251_bib15","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"key":"10.1016\/j.ejca.2023.113251_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjd.15324","article-title":"Cutaneous squamous cell carcinoma: an epidemiological review","volume":"177","author":"Green","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","article-title":"Cutaneous squamous-cell carcinoma","volume":"344","author":"Alam","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.113251_bib20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of non-melanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib21","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/bjd.15110","article-title":"Predicted cases of United Kingdom\u00a0skin squamous cell carcinoma and basal cell carcinoma in 2020 and 2025: horizon planning for National Health Service dermatology and dermatopathology","volume":"176","author":"Goon","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib22","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1001\/jama.1989.03430150065027","article-title":"The emerging epidemic of melanoma and squamous cell skin cancer","volume":"262","author":"Glass","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2023.113251_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archderm.1997.03890420073008","article-title":"Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992","volume":"133","author":"Gray","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5694\/mja17.00284","article-title":"The incidence and multiplicity rates of keratinocyte cancers in Australia","volume":"207","author":"Pandeya","year":"2017","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejca.2023.113251_bib25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bjd.12988","article-title":"Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention","volume":"171","author":"Deady","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamadermatol.2018.4219","article-title":"Nationwide incidence of metastatic cutaneous squamous cell carcinoma in England","volume":"155","author":"Venables","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.17873","article-title":"Epidemiology of basal and cutaneous squamous cell carcinoma in the UK\u00a02013\u201315: a cohort study","volume":"181","author":"Venables","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/cam4.404","article-title":"Cutaneous squamous cell carcinoma in Norway 1963-2011: increasing incidence and stable mortality","volume":"4","author":"Robsahm","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2023.113251_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/1346-8138.14759","article-title":"Incidence rate of cutaneous squamous cell carcinoma is rapidly increasing in Akita Prefecture: urgent alert for super-aged society","volume":"46","author":"Umezono","year":"2019","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib31","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.mayocp.2017.02.015","article-title":"Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010","volume":"92","author":"Muzic","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejca.2023.113251_bib32","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1111\/jdv.14052","article-title":"Non-melanoma skin cancer mortality rising in susceptible Australians","volume":"31","author":"Czarnecki","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113251_bib33","first-page":"e69","article-title":"Incidence of cutaneous squamous cell carcinoma in coastal and inland areas of Western Sweden","volume":"35","author":"Andersson","year":"2011","journal-title":"Cancer\u00a0Epidemiol"},{"key":"10.1016\/j.ejca.2023.113251_bib34","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jamadermatol.2013.5273","article-title":"Press for an underestimated nemesis","volume":"149","author":"Carucci","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the US","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jaad.2014.10.028","article-title":"Increased incidence and recurrence rates of non-melanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota","volume":"72","author":"Brewer","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaad.2018.03.024","article-title":"Risk of skin cancer in patients with HIV: a Danish nationwide cohort study","volume":"79","author":"Omland","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jid.2018.08.025","article-title":"Reduced-intensity conditioning regimens, prior chronic lymphocytic leukemia, and graft-versus-host disease are associated with higher rates of skin cancer after allogeneic hematopoietic stem cell transplantation","volume":"139","author":"Wu","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamadermatol.2015.3902","article-title":"Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study","volume":"152","author":"Omland","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib40","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/jamadermatol.2017.1716","article-title":"Association of multiple primary skin cancers with human immunodeficiency virus infection, CD4 count, and viral load","volume":"153","author":"Asgari","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib41","first-page":"811","article-title":"The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors","volume":"106","author":"Brougham","year":"2012","journal-title":"J\u00a0Surg\u00a0Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib44","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/jso.24707","article-title":"Low incidence of metastasis and recurrence from cutaneous squamous cell carcinoma found in a UK population: do we need to adjust our thinking on this rare but potentially fatal event?","volume":"116","author":"Nelson","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jdv.17709","article-title":"Epidemiology of advanced cutaneous squamous cell carcinoma","volume":"36","author":"Dessinioti","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113251_bib46","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/bjd.14352","article-title":"Survival with non-melanoma skin cancer in Germany","volume":"174","author":"Eisemann","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaad.2021.09.067","article-title":"Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: a nationwide cancer registry study","volume":"86","author":"Tokez","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib48","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/cncr.30601","article-title":"A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck","volume":"123","author":"Manyam","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hed.23283","article-title":"Cancer of the head and neck region in solid organ transplant recipients","volume":"36","author":"Rabinovics","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2023.113251_bib50","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1159\/000524460","article-title":"A sensitivity meta-analysis of disease-specific death in localized cutaneous squamous cell carcinoma","volume":"238","author":"Dessinioti","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.ejca.2023.113251_bib51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamaoto.2018.4515","article-title":"Outcomes of cutaneous squamous cell carcinoma in the head and neck region with regional lymph node metastasis: a systematic review and meta-analysis","volume":"145","author":"Sahovaler","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib52","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hed.25069","article-title":"Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: poor outcome unrelated to the index lesion","volume":"40","author":"Lam","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2023.113251_bib53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2016.02.1155","article-title":"Trends of skin cancer mortality after transplantation in the US: 1987 to 2013","volume":"75","author":"Garrett","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib54","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jaad.2005.08.055","article-title":"Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia","volume":"53","author":"Mehrany","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib55","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamadermatol.2013.6249","article-title":"Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia","volume":"150","author":"Velez","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib56","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3875","article-title":"Cutaneous squamous cell carcinoma in Epidermolysis Bullosa: a 28-year retrospective study","volume":"101","author":"Robertson","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2023.113251_bib57","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jid.2017.06.025","article-title":"Survival of patients with cutaneous squamous cell carcinoma: results of a prospective cohort study","volume":"137","author":"Eigentler","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib58","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jamadermatol.2018.1118","article-title":"Prevalence of skin cancer examination among users of indoor tanning beds","volume":"154","author":"Morris","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib59","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bjd.15932","article-title":"Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma","volume":"177","author":"Harwood","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib60","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamadermatol.2015.4530","article-title":"Association between beta-genus human papillomavirus and cutaneous squamous cell carcinoma in immunocompetent individuals\u2014a meta-analysis","volume":"152","author":"Chahoud","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib61","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/bjd.18212","article-title":"The detection rate of human papillomavirus in well-differentiated squamous cell carcinoma and keratoacanthoma: is there new evidence for a viral pathogenesis of keratoacanthoma?","volume":"181","author":"Conforti","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib62","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41416-018-0105-y","article-title":"Heterogeneous relationships of squamous and basal cell carcinomas of the skin with smoking: the UK Million Women Study and meta-analysis of prospective studies","volume":"119","author":"Pirie","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib63","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jid.2017.03.027","article-title":"Cigarette smoking and the risks of basal cell carcinoma and squamous cell carcinoma","volume":"137","author":"Dusingize","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib64","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ccell.2016.04.004","article-title":"Squamous cell cancers: a unified perspective on biology and genetics","volume":"29","author":"Dotto","year":"2016","journal-title":"Cancer cell"},{"key":"10.1016\/j.ejca.2023.113251_bib65","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"1","author":"Marks","year":"1988","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejca.2023.113251_bib66","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: a systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib67","doi-asserted-by":"crossref","first-page":"83280","DOI":"10.18632\/oncotarget.21059","article-title":"Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF\/MEK inhibitors in cancer patients: a meta-analysis","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2023.113251_bib68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cell.2009.12.040","article-title":"Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF","volume":"140","author":"Heidorn","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2023.113251_bib69","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF","volume":"464","author":"Poulikakos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2023.113251_bib70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","article-title":"RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors","volume":"366","author":"Su","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.113251_bib71","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jamadermatol.2015.4330","article-title":"Increased risk of cutaneous squamous cell carcinoma after vismodegib therapy for basal cell carcinoma","volume":"152","author":"Mohan","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib72","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/jamadermatol.2016.0780","article-title":"Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies","volume":"152","author":"Jacobsen","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib73","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/bjd.16713","article-title":"Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma","volume":"179","author":"Su","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib74","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2017.11.042","article-title":"Hydrochlorothiazide use and risk of non-melanoma skin cancer: a nationwide case-control study from Denmark","volume":"78","author":"Pedersen","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib75","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2018.1652","article-title":"Association of hydrochlorothiazide use and risk of malignant melanoma","volume":"178","author":"Pottegard","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejca.2023.113251_bib76","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00228-022-03299-x","article-title":"Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: a systematic review and meta-analysis","volume":"78","author":"de Macedo Andrade","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejca.2023.113251_bib77","unstructured":"European Medicines Agency. PRAC recommendation on signals."},{"key":"10.1016\/j.ejca.2023.113251_bib78","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/bjd.19880","article-title":"Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group","volume":"185","author":"Schneider","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib79","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/jid.2014.154","article-title":"NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis","volume":"134","author":"South","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib80","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat\u00a0Commun"},{"key":"10.1016\/j.ejca.2023.113251_bib81","article-title":"Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates","volume":"7","author":"Chitsazzadeh","year":"2016","journal-title":"Nat\u00a0Commun"},{"key":"10.1016\/j.ejca.2023.113251_bib82","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome\u00a0Med"},{"key":"10.1016\/j.ejca.2023.113251_bib83","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2023.113251_bib84","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jid.2021.07.172","article-title":"Genomic progression of precancerous actinic keratosis to squamous cell carcinoma","volume":"142","author":"Kim","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib85","article-title":"Inactivation of TGFbeta receptors in stem cells drives cutaneous squamous cell carcinoma","volume":"7","author":"Cammareri","year":"2016","journal-title":"Nat\u00a0Commun"},{"key":"10.1016\/j.ejca.2023.113251_bib86","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cncr.29738","article-title":"Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies","volume":"122","author":"Al-Rohil","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-021-00226-4","article-title":"The landscape of driver mutations in cutaneous squamous cell carcinoma","volume":"6","author":"Chang","year":"2021","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.ejca.2023.113251_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aas9668","article-title":"APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa","author":"Cho","year":"2018","journal-title":"Sci Trans Med"},{"key":"10.1016\/j.ejca.2023.113251_bib89","article-title":"Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma","volume":"7","author":"Chahal","year":"2016","journal-title":"Nat\u00a0Commun"},{"key":"10.1016\/j.ejca.2023.113251_bib90","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jid.2017.09.034","article-title":"Susceptibility loci-associated cutaneous squamous cell carcinoma invasiveness","volume":"138","author":"Wang","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib91","article-title":"Gene expression imputation identifies candidate genes and susceptibility loci associated with cutaneous squamous cell carcinoma","volume":"9","author":"Ioannidis","year":"2018","journal-title":"Nat\u00a0Commun"},{"key":"10.1016\/j.ejca.2023.113251_bib92","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jid.2018.01.031","article-title":"Quantifying the polygenic contribution to cutaneous squamous cell carcinoma risk","volume":"138","author":"Sordillo","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib93","article-title":"Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma","volume":"11","author":"Sarin","year":"2020","journal-title":"Nat\u00a0Commun"},{"key":"10.1016\/j.ejca.2023.113251_bib94","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-22-1332","article-title":"High-dimensional and spatial analysis reveals immune landscape-dependent progression in cutaneous squamous cell carcinoma","volume":"28","author":"Ferguson","year":"2022","journal-title":"Clin\u00a0Cancer\u00a0Res"},{"key":"10.1016\/j.ejca.2023.113251_bib95","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00262-018-2138-8","article-title":"PD-L1, B7-H3, and PD-1 expression in immunocompetent versus\u00a0immunosuppressed patients with cutaneous squamous cell carcinoma","volume":"67","author":"Varki","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ejca.2023.113251_bib96","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bjd.14955","article-title":"The pattern and clinicopathological correlates of programmed death-ligand 1 expression in cutaneous squamous cell carcinoma","volume":"176","author":"Schaper","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib97","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/DAD.0000000000001164","article-title":"PD-L1 expression is increased in metastasizing squamous cell carcinomas and their metastases","volume":"40","author":"Garcia-Diez","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2023.113251_bib98","series-title":"WHO Classification of Skin Tumours","first-page":"35","article-title":"Squamous cell carcinoma","author":"Murphy","year":"2018"},{"key":"10.1016\/j.ejca.2023.113251_bib99","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/DAD.0000000000000031","article-title":"Keratoacanthoma clinical behavior: a systematic review","volume":"36","author":"Savage","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2023.113251_bib100","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archdermatol.2012.2974","article-title":"Dermoscopy of squamous cell carcinoma and keratoacanthoma","volume":"148","author":"Rosendahl","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib101","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/bjd.13510","article-title":"The clinical and dermoscopic features of invasive cutaneous squamous cell carcinoma depend on the histopathological grade of differentiation","volume":"172","author":"Lallas","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib102","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaad.2011.02.011","article-title":"Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model","volume":"66","author":"Zalaudek","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib103","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archdermatol.2009.134","article-title":"Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses","volume":"145","author":"Rishpon","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib104","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/jdv.14463","article-title":"Dermoscopic and reflectance confocal microscopy features of cutaneous squamous cell carcinoma","volume":"31","author":"Manfredini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113251_bib105","article-title":"Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults","volume":"12","author":"Dinnes","year":"2018","journal-title":"Cochrane\u00a0Database\u00a0Syst\u00a0Rev"},{"key":"10.1016\/j.ejca.2023.113251_bib106","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/jdv.12954","article-title":"High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma","volume":"29","author":"Boone","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113251_bib107","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/jdv.14335","article-title":"In vivo microvascular imaging of cutaneous actinic keratosis, Bowen's disease and squamous cell carcinoma using dynamic optical coherence tomography","volume":"31","author":"Themstrup","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113251_bib108","article-title":"Optical coherence tomography for diagnosing skin cancer in adults","volume":"12","author":"Ferrante di Ruffano","year":"2018","journal-title":"Cochrane\u00a0Database\u00a0Syst\u00a0Rev"},{"key":"10.1016\/j.ejca.2023.113251_bib109","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamadermatol.2017.4506","article-title":"Cutaneous squamous cell carcinomas in solid organ transplant recipients compared with immunocompetent patients","volume":"154","author":"Cheng","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib110","first-page":"130","article-title":"Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends","volume":"54","author":"Kallini","year":"2015","journal-title":"Int\u00a0J\u00a0Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib111","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2559.2000.00999.x","article-title":"Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin","volume":"37","author":"Beer","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2023.113251_bib112","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/(SICI)1097-0142(19970301)79:5<915::AID-CNCR7>3.0.CO;2-A","article-title":"Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer","volume":"79","author":"Breuninger","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib113","series-title":"AJCC Cancer Staging Manual","first-page":"171","article-title":"Cutaneous carcinoma of the head and neck","author":"Califano","year":"2017"},{"key":"10.1016\/j.ejca.2023.113251_bib114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2013.746","article-title":"Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study","volume":"149","author":"Carter","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib115","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jid.2020.01.035","article-title":"Prognostic impact of perineural invasion in cutaneous squamous cell carcinoma: results of a prospective study of 1399 tumors","volume":"140","author":"Haug","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib116","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/DSS.0000000000003324","article-title":"Local tumor infiltration and locoregional recurrence in desmoplastic cutaneous squamous cell carcinoma","volume":"48","author":"Kofler","year":"2022","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143556","article-title":"Recent advances in the diagnosis and management of high-risk cutaneous squamous cell carcinoma","volume":"14","author":"Dessinioti","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2023.113251_bib118","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2559.2006.02472.x","article-title":"Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips","volume":"49","author":"Quaedvlieg","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2023.113251_bib119","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s10147-020-01830-7","article-title":"Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients","volume":"26","author":"Saito","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaad.2022.02.056","article-title":"Risk factors for metastatic cutaneous squamous cell carcinoma: refinement and replication based on two nationwide nested case-control studies","volume":"87","author":"Tokez","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib121","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/DSS.0000000000003324","article-title":"Local tumor infiltration and locoregional recurrence in desmoplastic cutaneous squamous cell carcinoma","volume":"48","author":"Kofler","year":"2022","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib122","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2022.05.043","article-title":"What causes the death of patients with cutaneous squamous cell carcinoma? A prospective analysis in 1400 patients","volume":"172","author":"Eigentler","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib123","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/bjd.21250","article-title":"Risk factors for distant metastasis in cutaneous squamous cell carcinoma","volume":"187","author":"Stefanovic","year":"2022","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2023.113251_bib124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jdv.17531","article-title":"Overview of guideline recommendations for the management of high-risk and advanced cutaneous squamous cell carcinoma","volume":"36","author":"Dessinioti","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113251_bib125","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaad.2022.08.050","article-title":"Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: a dual center retrospective cohort analysis of primary N0 disease","volume":"87","author":"O\u2019Connor","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib126","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaad.2018.09.015","article-title":"Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone","volume":"80","author":"Marrazzo","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib127","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaad.2020.04.088","article-title":"Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma","volume":"84","author":"Wysong","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib128","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/fon-2021-1277","article-title":"Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test","volume":"18","author":"Ibrahim","year":"2022","journal-title":"Future Oncol (London, England)"},{"key":"10.1016\/j.ejca.2023.113251_bib129","first-page":"268","article-title":"Prognostic factors for metastasis in squamous cell carcinoma of the skin","volume":"28","author":"Cherpelis","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib130","first-page":"37","article-title":"Squamous cell carcinoma of the skin-histopathological features and their significance for the clinical outcome","volume":"11","author":"Petter","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113251_bib131","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jaad.2021.11.002","article-title":"Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion","volume":"86","author":"Kus","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib132","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamadermatol.2017.1680","article-title":"Clinical and incidental perineural invasion of cutaneous squamous cell carcinoma: a systematic review and pooled analysis of outcomes data","volume":"153","author":"Karia","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib133","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/DSS.0000000000003553","article-title":"Squamous cell carcinoma with bone invasion: a systematic review and pooled survival analysis","volume":"48","author":"Russell","year":"2022","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib134","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib135","first-page":"579","article-title":"Comparison and evaluation of the current staging of cutaneous carcinomas","volume":"10","author":"Breuninger","year":"2012","journal-title":"J\u00a0Ger\u00a0Soc\u00a0Dermatol: JDDG"},{"key":"10.1016\/j.ejca.2023.113251_bib136","first-page":"1298","article-title":"N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of two Australian","volume":"116","author":"Forest","year":"2010"},{"key":"10.1016\/j.ejca.2023.113251_bib137","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/cncr.24208","article-title":"Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, treatment, extranodal spread, and margin status (ITEM) prognostic score to predict outcome and the need to improve survival","volume":"115","author":"Oddone","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib138","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2019.0032","article-title":"Performance of the American joint committee on cancer staging manual, 8th edition versus\u00a0the Brigham and women's hospital tumor classification system for cutaneous squamous cell carcinoma","volume":"155","author":"Ruiz","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib139","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jaad.2020.03.088","article-title":"Definition of prognostic subgroups in the T3 stage of the eighth edition of the American joint committee on cancer staging system for cutaneous squamous cell carcinoma: tentative T3 stage subclassification","volume":"85","author":"Conde-Ferreiros","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib140","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjd.20909","article-title":"Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data","volume":"186","author":"Venables","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib141","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamadermatol.2017.6428","article-title":"Validating four staging systems for cutaneous squamous cell carcinoma using population-based data: a nested case-control study","volume":"154","author":"Roscher","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib142","first-page":"1531","article-title":"A critical analysis of the 8th edition TNM staging for head and neck cutaneous squamous cell carcinoma with lymph node metastases and comparison to N1S3 stage and ITEM risk score: a multicenter study","volume":"123","author":"Ebrahimi","year":"2021","journal-title":"J\u00a0Surg\u00a0Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib143","article-title":"Number of nodal metastases and the American joint committee on cancer staging of head and neck cutaneous squamous cell carcinoma: a multicenter study","volume":"111","author":"Ebrahimi","year":"2020","journal-title":"Oral\u00a0Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib144","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamadermatol.2022.0001","article-title":"Implications of satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: a prognostic omission in cancer staging systems","volume":"158","author":"Smile","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib145","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3498","article-title":"Update of the management of cutaneous squamous-cell carcinoma","volume":"100","author":"Maubec","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2023.113251_bib146","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jaad.2018.09.006","article-title":"Nodal staging of high-risk cutaneous squamous cell carcinoma","volume":"81","author":"Fox","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib147","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bjoms.2014.01.015","article-title":"Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma","volume":"52","author":"Gurney","year":"2014","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib148","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejrad.2007.02.037","article-title":"Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging","volume":"64","author":"de Bondt","year":"2007","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejca.2023.113251_bib149","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/ijgc-00009577-200601000-00050","article-title":"Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva","volume":"16","author":"Land","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib150","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jaad.2019.10.067","article-title":"Detection of subclinical disease with baseline and surveillance imaging in high-risk cutaneous squamous cell carcinomas","volume":"82","author":"Maher","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib151","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamadermatol.2021.4990","article-title":"Assessment of the diagnostic accuracy of baseline clinical examination and ultrasonographic imaging for the detection of lymph node metastasis in patients with high-risk cutaneous squamous cell carcinoma of the head and neck","volume":"158","author":"Tokez","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib152","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jaad.2015.10.009","article-title":"The role of imaging in the management of patients with non-melanoma skin cancer: when is imaging necessary?","volume":"76","author":"Humphreys","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib153","first-page":"1061","article-title":"Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis","volume":"49","author":"Williams","year":"2001","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Oncol\u00a0Biol\u00a0Phys"},{"key":"10.1016\/j.ejca.2023.113251_bib154","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaad.2015.10.010","article-title":"The role of imaging in the management of patients with non-melanoma skin cancer: diagnostic modalities and applications","volume":"76","author":"MacFarlane","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2016.08.051","article-title":"The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management","volume":"76","author":"Ruiz","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib156","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/hed.23982","article-title":"Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma","volume":"38","author":"Warren","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2023.113251_bib157","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/hed.21470","article-title":"Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing \u2018targeted\u2019\u00a0MRI with the histologic findings following surgery","volume":"33","author":"Gandhi","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2023.113251_bib158","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hed.21986","article-title":"Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck","volume":"34","author":"Panizza","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2023.113251_bib159","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/1346-8138.14342","article-title":"Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma","volume":"45","author":"Tejera-Vaquerizo","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaad.2015.03.039","article-title":"High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: a literature review","volume":"73","author":"Navarrete-Dechent","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib161","first-page":"786","article-title":"Sentinel lymph node biopsy for high-risk non-melanoma skin cancers","volume":"33","author":"Sahn","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib162","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/bjd.13508","article-title":"Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma","volume":"172","author":"Krediet","year":"2015","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2023.113251_bib163","first-page":"E884","article-title":"Prospective study of sentinel node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck","volume":"38","author":"Gore","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2023.113251_bib164","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/1346-8138.12508","article-title":"Evaluation of sentinel node biopsy for cutaneous squamous cell carcinoma","volume":"41","author":"Fukushima","year":"2014","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib165","first-page":"135","article-title":"Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma","volume":"29","author":"Reschly","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib166","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamadermatol.2013.6675","article-title":"Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American joint committee on cancer criteria and a proposed alternative system","volume":"150","author":"Schmitt","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib167","first-page":"119","article-title":"Sentinel lymph node biopsy for high-thickness cutaneous squamous cell carcinoma","volume":"313","author":"Kofler","year":"2021","journal-title":"Arch\u00a0Dermatol\u00a0Res"},{"key":"10.1016\/j.ejca.2023.113251_bib168","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jss.2019.03.040","article-title":"Cost-effectiveness of sentinel lymph node biopsy for head and neck cutaneous squamous cell carcinoma","volume":"241","author":"Quinn","year":"2019","journal-title":"J Surg Res"},{"key":"10.1016\/j.ejca.2023.113251_bib169","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1002\/hed.27121","article-title":"Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma of the head and neck: systematic review and meta-analysis","volume":"44","author":"Costantino","year":"2022","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2023.113251_bib170","first-page":"1309","article-title":"Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature","volume":"32","author":"Ross","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib171","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejso.2006.10.017","article-title":"Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature","volume":"33","author":"Renzi","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib172","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejso.2014.10.055","article-title":"Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma","volume":"41","author":"Allen","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib173","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2340\/00015555-2942","article-title":"Sentinel lymph node biopsy in cutaneous squamous cell carcinoma series of 37 cases and systematic review of the literature","volume":"98","author":"Lhote","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2023.113251_bib174","first-page":"422","article-title":"Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic review","volume":"27","author":"Saraiya","year":"2004","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ejca.2023.113251_bib175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/0278-6133.25.1.34","article-title":"Evaluation of a multicomponent appearance-based sun-protective intervention for young women: uncovering the mechanisms of program efficacy","volume":"25","author":"Jackson","year":"2006","journal-title":"Health Psychol"},{"key":"10.1016\/j.ejca.2023.113251_bib176","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/CEJ.0000000000000056","article-title":"Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review","volume":"24","author":"Gordon","year":"2015","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ejca.2023.113251_bib177","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.2017.21630","article-title":"Behavioral counseling for skin cancer prevention: evidence report and systematic review for the US\u00a0preventive services task force","volume":"319","author":"Henrikson","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2023.113251_bib178","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.amepre.2016.03.020","article-title":"Community-wide interventions to prevent skin cancer: two community guide systematic reviews","volume":"51","author":"Sandhu","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ejca.2023.113251_bib179","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1080\/10810730.2013.778361","article-title":"Randomized trial of tailored skin cancer prevention for children: the Project SCAPE family study","volume":"18","author":"Glanz","year":"2013","journal-title":"J Health Commun"},{"key":"10.1016\/j.ejca.2023.113251_bib180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ypmed.2014.12.009","article-title":"Can skin cancer prevention and early detection be improved via mobile phone text messaging? A randomised, attention control trial","volume":"71","author":"Youl","year":"2015","journal-title":"Prev Med"},{"key":"10.1016\/j.ejca.2023.113251_bib181","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(98)12168-2","article-title":"Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial","volume":"354","author":"Green","year":"1999","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejca.2023.113251_bib182","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1158\/1055-9965.EPI-06-0352","article-title":"Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use","volume":"15","author":"van der Pols","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2023.113251_bib183","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJM199310143291602","article-title":"Reduction of solar keratoses by regular sunscreen use","volume":"329","author":"Thompson","year":"1993","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.ejca.2023.113251_bib184","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","article-title":"Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study","volume":"161","author":"Ulrich","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib185","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1684\/ejd.2018.3251","article-title":"Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis","volume":"28","author":"Silva","year":"2018","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib186","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/ijc.31997","article-title":"Challenges in assessing the sunscreen-melanoma association","volume":"144","author":"Rueegg","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib187","first-page":"875","article-title":"New developments in occupational dermatology","volume":"14","author":"Diepgen","year":"2016","journal-title":"J\u00a0Ger\u00a0Soc\u00a0Dermatol: JDDG"},{"key":"10.1016\/j.ejca.2023.113251_bib188","first-page":"66","article-title":"ICNIRP statement\u2013protection of workers against ultraviolet radiation","volume":"99","year":"2010","journal-title":"Health\u00a0Phys"},{"key":"10.1016\/j.ejca.2023.113251_bib189","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.seminoncol.2016.02.019","article-title":"Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment","volume":"43","author":"Kim","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib190","first-page":"119","article-title":"A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population","volume":"13","author":"Harwood","year":"2013","journal-title":"Am\u00a0J\u00a0Transplant"},{"key":"10.1016\/j.ejca.2023.113251_bib191","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ypmed.2005.11.007","article-title":"A randomized intervention study of sun protection promotion in well-child care","volume":"42","author":"Crane","year":"2006","journal-title":"Prev Med"},{"key":"10.1016\/j.ejca.2023.113251_bib192","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5993\/AJHB.34.4.11","article-title":"The sun sense study: an intervention to improve sun protection in children","volume":"34","author":"Glasser","year":"2010","journal-title":"Am J Health Behav"},{"key":"10.1016\/j.ejca.2023.113251_bib193","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archpedi.161.2.146","article-title":"A randomized trial of a multicomponent intervention for adolescent sun protection behaviors","volume":"161","author":"Norman","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ejca.2023.113251_bib194","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/109019810102800304","article-title":"Slip! Slop! Slap! and SunSmart, 1980\u20132000: skin cancer control and 20 years of population-based campaigning","volume":"28","author":"Montague","year":"2001","journal-title":"Health Educ Behav"},{"issue":"Suppl 3","key":"10.1016\/j.ejca.2023.113251_bib195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2009.09443.x","article-title":"Certification of sun protection practices in a German child day-care centre improves children's sun protection\u2014the 'SunPass' pilot study","volume":"161","author":"Aulbert","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib196","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/her\/16.5.623","article-title":"Evaluation of 'Sun-safe': a health education resource for primary schools","volume":"16","author":"Hewitt","year":"2001","journal-title":"Health Educ Res"},{"key":"10.1016\/j.ejca.2023.113251_bib197","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/109019819902600307","article-title":"The Falmouth Safe Skin Project: evaluation of a community program to promote sun protection in youth","volume":"26","author":"Miller","year":"1999","journal-title":"Health Educ Behav"},{"key":"10.1016\/j.ejca.2023.113251_bib198","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.det.2019.02.004","article-title":"Topical and systemic modalities for chemoprevention of non-melanoma skin cancer","volume":"37","author":"Nemer","year":"2019","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ejca.2023.113251_bib199","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/cncr.26374","article-title":"Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251)","volume":"118","author":"Kadakia","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib200","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1067\/S0190-9622(03)01587-1","article-title":"Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study","volume":"49","author":"Nijsten","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib201","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/bjd.12519","article-title":"Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors","volume":"169","author":"Anforth","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib202","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archderm.141.4.456","article-title":"Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study","volume":"141","author":"Harwood","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib203","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2133.2005.06347.x","article-title":"Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials","volume":"152","author":"Chen","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib204","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.jid.5701058","article-title":"UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide","volume":"128","author":"Damian","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/12034754221078201","article-title":"Effect of nicotinamide in skin cancer and actinic keratoses chemoprophylaxis, and adverse effects related to nicotinamide: a systematic review and meta-analysis","volume":"26","author":"Mainville","year":"2022","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib206","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.113251_bib207","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/jid.2014.531","article-title":"Aspirin and non-steroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis","volume":"135","author":"Muranushi","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib208","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ijc.29357","article-title":"Non-steroidal anti-inflammatory drugs and the risk of non-melanoma skin cancer","volume":"137","author":"Reinau","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2023.113251_bib209","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/bjd.17938","article-title":"Aspirin and non-steroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia","volume":"181","author":"Pandeya","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib210","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.2011.34.5967","article-title":"Calcium plus vitamin D supplementation and the risk of non-melanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial","volume":"29","author":"Tang","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib211","first-page":"1532","article-title":"Risk of keratinocyte carcinomas with vitamin D and calcium supplementation: a secondary analysis of a randomized clinical trial","volume":"112","author":"Passarelli","year":"2020","journal-title":"Am\u00a0J\u00a0Clin\u00a0Nutr"},{"key":"10.1016\/j.ejca.2023.113251_bib212","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamadermatol.2017.3631","article-title":"Chemoprevention of basal and squamous cell carcinoma with a single course of fluorouracil, 5%, cream: a randomized clinical trial","volume":"154","author":"Weinstock","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib213","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125476","article-title":"Skin cancer precursor immunotherapy for squamous cell carcinoma prevention","author":"Rosenberg","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejca.2023.113251_bib214","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib215","first-page":"522","article-title":"Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: population-based cohort study","volume":"19","author":"Chan","year":"2019","journal-title":"Am\u00a0J\u00a0Transplant"},{"key":"10.1016\/j.ejca.2023.113251_bib216","first-page":"598","article-title":"Specialty clinics for the dermatologic care of solid-organ transplant recipients","volume":"30","author":"Christenson","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib217","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2006.07454.x","article-title":"Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness","volume":"155","author":"Ismail","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib218","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/bjd.16836","article-title":"Increase in preventive behaviour by organ transplant recipients after sun protection information in a skin cancer surveillance clinic","volume":"179","author":"Papier","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib219","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jamadermatol.2018.1164","article-title":"Sun protection among organ transplant recipients after participation in a skin cancer research study","volume":"154","author":"Hartman","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib220","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/TP.0000000000002641","article-title":"Interventions to prevent non-melanoma skin cancers in recipients of a solid organ transplant: systematic review of randomized controlled trials","volume":"103","author":"Chung","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ejca.2023.113251_bib221","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029265","article-title":"Behavioural and pharmaceutical interventions for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomised controlled trials","volume":"10","author":"James","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejca.2023.113251_bib222","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamadermatol.2021.3180","article-title":"Consensus-based recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: a Delphi consensus statement","volume":"157","author":"Massey","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.ejca.2023.113251_bib223","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am\u00a0J\u00a0Transplant"},{"key":"10.1016\/j.ejca.2023.113251_bib224","first-page":"642","article-title":"Guidelines for the management of squamous cell carcinoma in organ transplant recipients","volume":"30","author":"Stasko","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib225","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jphotobiol.2010.04.001","article-title":"Dermatologic management, sun avoidance and vitamin D status in organ transplant recipients (OTR)","volume":"101","author":"Reichrath","year":"2010","journal-title":"J Photochem Photobiol B"},{"issue":"Suppl 4","key":"10.1016\/j.ejca.2023.113251_bib226","first-page":"19","article-title":"European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.3.1 Long-term immunosuppression. Late steroid or cyclosporine withdrawal","volume":"17","author":"Transplantation EEGoR","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejca.2023.113251_bib227","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1684\/ejd.2019.3639","article-title":"Risk behaviour and patient preferences for an improved non-melanoma skin cancer prevention modality for organ-transplanted patients: a European, multi-country, online patient community study","volume":"29","author":"Basset Seguin","year":"2019","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib228","first-page":"1215","article-title":"The burden of cutaneous disease in solid organ transplant recipients of color","volume":"21","author":"Kentley","year":"2021","journal-title":"Am\u00a0J\u00a0Transplant"},{"issue":"8","key":"10.1016\/j.ejca.2023.113251_bib229","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib230","first-page":"269","article-title":"Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients","volume":"43","author":"George","year":"2002","journal-title":"Aust\u00a0J\u00a0Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib231","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1067\/S0190-9622(03)01831-0","article-title":"Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin","volume":"49","author":"de Sevaux","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib232","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/DSS.0000000000002423","article-title":"Efficacy and cost analysis for acitretin for basal and squamous cell carcinoma prophylaxis in renal transplant recipients","volume":"47","author":"Badri","year":"2021","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib233","first-page":"662","article-title":"Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma","volume":"30","author":"Martinez","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib234","first-page":"562","article-title":"Chemoprevention of non-melanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects","volume":"32","author":"Otley","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib235","first-page":"749","article-title":"Is the first-line systemic chemoprevention of non-melanoma skin cancer nicotinamide or acitretin?","volume":"60","author":"Hoegler","year":"2021","journal-title":"Int\u00a0J\u00a0Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib236","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.07087.x","article-title":"Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey","volume":"154","author":"Otley","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib237","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjd.14662","article-title":"A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients","volume":"175","author":"Chen","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib238","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1684\/ejd.2017.3025","article-title":"Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study","volume":"27","author":"Drago","year":"2017","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib239","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMoa2203086","article-title":"Nicotinamide for skin-cancer chemoprevention in transplant recipients","volume":"388","author":"Allen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.113251_bib240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/CAD.0b013e3282f945aa","article-title":"Capecitabine: an overview of the side-effects and their management","volume":"19","author":"Saif","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ejca.2023.113251_bib241","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1399-0012.2010.01348.x","article-title":"Capecitabine for skin cancer prevention in solid organ transplant recipients","volume":"25","author":"Jirakulaporn","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ejca.2023.113251_bib242","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/dsu.12049","article-title":"Capecitabine to reduce non-melanoma skin carcinoma burden in solid organ transplant recipients","volume":"39","author":"Endrizzi","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113251_bib243","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamadermatol.2020.2327","article-title":"Evaluation of the use of capecitabine for the treatment and prevention of actinic keratoses, squamous cell carcinoma, and basal cell carcinoma: a systematic review","volume":"156","author":"Schauder","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib244","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaad.2020.03.127","article-title":"Field cancerization: treatment","volume":"83","author":"Cornejo","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib245","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjd.15950","article-title":"Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"177","author":"Blomberg","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib246","first-page":"565","article-title":"Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the skin cancer after organ transplant (SCOT) cohort","volume":"16","author":"Coghill","year":"2016","journal-title":"Am\u00a0J\u00a0Transplant"},{"key":"10.1016\/j.ejca.2023.113251_bib247","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.healun.2018.03.012","article-title":"Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation","volume":"37","author":"Vos","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ejca.2023.113251_bib248","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaad.2019.09.070","article-title":"Belatacept reduces skin cancer risk in kidney transplant recipients","volume":"82","author":"Wang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib249","first-page":"1385","article-title":"Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and non-melanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial","volume":"10","author":"Salgo","year":"2010","journal-title":"Am\u00a0J\u00a0Transplant"},{"key":"10.1016\/j.ejca.2023.113251_bib250","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.113251_bib251","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1200\/JCO.2012.45.6376","article-title":"Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus","volume":"31","author":"Hoogendijk-van den Akker","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2023.113251_bib252","first-page":"1146","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for non-melanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am\u00a0J\u00a0Transplant"},{"key":"10.1016\/j.ejca.2023.113251_bib253","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaad.2015.05.029","article-title":"Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)","volume":"73","author":"Asgari","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib254","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/ijd.14549","article-title":"Mammalian target of rapamycin (mTOR) inhibitors and skin cancer risk in non-renal solid organ transplant recipients: systematic review and meta-analysis","volume":"59","author":"Phan","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib255","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2023.113251_bib256","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2015.5548","article-title":"Association of sirolimus use with risk for skin cancer in a mixed-organ cohort of solid-organ transplant recipients with a history of cancer","volume":"152","author":"Karia","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib257","first-page":"1974","article-title":"Chemotherapy and Transplantation: the role of immunosuppression in malignancy and a review of antineoplastic agents in solid organ transplant recipients","volume":"17","author":"Krisl","year":"2017","journal-title":"Am\u00a0J\u00a0Transplant"},{"key":"10.1016\/j.ejca.2023.113251_bib258","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10880","article-title":"Interventions after first post-transplant cutaneous squamous cell carcinoma: a proposed decision framework","volume":"35","author":"Bottomley","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejca.2023.113251_bib259","first-page":"103","article-title":"Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines","volume":"17","author":"Acuna","year":"2017","journal-title":"Am\u00a0J\u00a0Transplant"},{"key":"10.1016\/j.ejca.2023.113251_bib260","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/tri.13520","article-title":"Initial skin cancer screening for solid organ transplant recipients in the US: Delphi method development of expert consensus guidelines","volume":"32","author":"Crow","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejca.2023.113251_bib261","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/tri.13493","article-title":"Predicting skin cancer in organ transplant recipients: development of the SUNTRAC screening tool using data from a multicenter cohort study","volume":"32","author":"Jambusaria-Pahlajani","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejca.2023.113251_bib262","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/bjd.15889","article-title":"Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature","volume":"177","author":"Lowenstein","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113251_bib263","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1200\/JOP.2013.000921","article-title":"Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia","volume":"10","author":"Mansfield","year":"2014","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.ejca.2023.113251_bib264","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1080\/10428194.2019.1620941","article-title":"Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival","volume":"60","author":"Ishdorj","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2023.113251_bib265","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1007\/s10620-018-5056-x","article-title":"Low rates of dermatologic care and skin cancer screening among inflammatory bowel disease patients","volume":"63","author":"Anderson","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"Suppl 5","key":"10.1016\/j.ejca.2023.113251_bib266","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04296.x","article-title":"Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions","volume":"25","author":"Bonerandi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923003532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923003532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:42:37Z","timestamp":1760733757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923003532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":266,"alternative-id":["S0959804923003532"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113251","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention\u2013Update 2023","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"113251"}}